Merck (MRK) in advanced talks to acquire Seagen (SGEN) for more than $200 per share - WSJ
Tweet Send to a Friend
Merck (NYSE: MRK) is in ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE